Endos will care if they see patients QOL improve due to Afrezza. Less complications, better compliance and improved health will be a blessing for over worked Endos. At least that's the thought.
As for insurance, you are correct. If insurance companies see the same thing, then maybe they will get on board.
But BP money is what makes them do what they do. And again you are right about MNKD not being able to play that game.
News 
Market Data 
Discover 
AI
